Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Ionis Pharmaceuticals Inc (NASDAQ: IONS) closed at $31.35 in the last session, down -1.29% from day before closing price of $31.76. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 0.84 million shares were traded.
Ratios:
We take a closer look at IONS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.43 and its Current Ratio is at 8.47. In the meantime, Its Debt-to-Equity ratio is 3.33 whereas as Long-Term Debt/Eq ratio is at 3.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on August 02, 2024, Downgraded its rating to Market Perform and sets its target price to $60 from $67 previously.
On July 24, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $53 to $62.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 20 ’25 when O’NEIL PATRICK R. sold 1,207 shares for $32.35 per share. The transaction valued at 39,046 led to the insider holds 56,245 shares of the business.
O’NEIL PATRICK R. sold 6,165 shares of IONS for $194,939 on Feb 04 ’25. The EVP CLO & General Counsel now owns 57,452 shares after completing the transaction at $31.62 per share. On Feb 04 ’25, another insider, Monia Brett P, who serves as the Chief Executive Officer of the company, sold 38,843 shares for $31.65 each. As a result, the insider received 1,229,463 and left with 180,683 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.06 while its Price-to-Book (P/B) ratio in mrq is 8.41.
Stock Price History:
Over the past 52 weeks, IONS has reached a high of $52.34, while it has fallen to a 52-week low of $30.23. The 50-Day Moving Average of the stock is -6.57%, while the 200-Day Moving Average is calculated to be -21.42%.
Shares Statistics:
A total of 157.91M shares are outstanding, with a floating share count of 154.56M. Insiders hold about 2.77% of the company’s shares, while institutions hold 100.76% stake in the company.
